BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10774587)

  • 1. Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks.
    Korba BE; Cote P; Hornbuckle W; Schinazi R; Gerin JL; Tennant BC
    Antiviral Res; 2000 Jan; 45(1):19-32. PubMed ID: 10774587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks.
    Korba BE; Cote P; Hornbuckle W; Schinazi R; Gangemi JD; Tennant BC; Gerin JL
    Antivir Ther; 2000 Jun; 5(2):95-104. PubMed ID: 10971862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
    Korba BE; Cote P; Hornbuckle W; Tennant BC; Gerin JL
    Hepatology; 2000 May; 31(5):1165-75. PubMed ID: 10796894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S; Cote PJ; Korba BE; Butler SD; George AL; Tochkov IA; Delaney WE; Xiong S; Gerin JL; Tennant BC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S; Butler SD; George AL; Tochkov IA; Zhu Y; Xiong S; Gerin JL; Cote PJ; Tennant BC
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3617-32. PubMed ID: 18676881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
    Peek SF; Cote PJ; Jacob JR; Toshkov IA; Hornbuckle WE; Baldwin BH; Wells FV; Chu CK; Gerin JL; Tennant BC; Korba BE
    Hepatology; 2001 Jan; 33(1):254-66. PubMed ID: 11124844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine.
    Tatti KM; Korba BE; Stang HL; Peek S; Gerin JL; Tennant BC; Schinazi RF
    Antiviral Res; 2002 Jul; 55(1):141-50. PubMed ID: 12076758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
    Le Guerhier F; Pichoud C; Jamard C; Guerret S; Chevallier M; Peyrol S; Hantz O; King I; Trépo C; Cheng YC; Zoulim F
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1065-77. PubMed ID: 11257017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S; Asif G; Narayanasamy J; Butler SD; George AL; Hurwitz SJ; Schinazi RF; Chu CK; Cote PJ; Gerin JL; Tennant BC
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3177-84. PubMed ID: 17606676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck (Marmota monax) model of chronic hepatitis B virus (HBV) infection.
    Genovesi EV; Lamb L; Medina I; Taylor D; Seifer M; Innaimo S; Colonno RJ; Clark JM
    Antiviral Res; 2000 Dec; 48(3):197-203. PubMed ID: 11164506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
    Jacob JR; Korba BE; Cote PJ; Toshkov I; Delaney WE; Gerin JL; Tennant BC
    Antiviral Res; 2004 Aug; 63(2):115-21. PubMed ID: 15302140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study on the effect of combination therapy with lamivudine and famciclovir against duck hepatitis B virus in vivo].
    Chen Y; Guo S; Qi Z; Huang A
    Zhonghua Gan Zang Bing Za Zhi; 2001 Aug; 9(4):209-11. PubMed ID: 11602049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.
    Zhou T; Guo JT; Nunes FA; Molnar-Kimber KL; Wilson JM; Aldrich CE; Saputelli J; Litwin S; Condreay LD; Seeger C; Mason WS
    J Virol; 2000 Dec; 74(24):11754-63. PubMed ID: 11090175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral dynamics in chronic hepatitis B patients treated with lamivudine, lamivudine-famciclovir or lamivudine-ganciclovir.
    Wolters LM; Hansen BE; Niesters HG; de Man RA
    Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1007-11. PubMed ID: 12352221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure.
    Ayres A; Bartholomeusz A; Lau G; Lam KC; Lee JY; Locarnini S
    J Clin Virol; 2003 May; 27(1):111-6. PubMed ID: 12727536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo.
    Tsiquaye KN; Slomka MJ; Maung M
    J Med Virol; 1994 Mar; 42(3):306-10. PubMed ID: 8006644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection.
    Menne S; Roneker CA; Tennant BC; Korba BE; Gerin JL; Cote PJ
    Intervirology; 2002; 45(4-6):237-50. PubMed ID: 12566706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine.
    Hervás-Stubbs S; Lasarte JJ; Sarobe P; Vivas I; Condreay L; Cullen JM; Prieto J; Borrás-Cuesta F
    J Hepatol; 2001 Jul; 35(1):105-11. PubMed ID: 11495027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks.
    Korolowicz KE; Suresh M; Li B; Huang X; Yon C; Kallakury BV; Lee KP; Park S; Kim YW; Menne S
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic hepatitis B: interferon-monotherapy or combination with nucleoside analogues?
    Tassopoulos NC
    Liver; 1998 Apr; 18(2):71-2. PubMed ID: 9588765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.